The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression

被引：132
|
作者：
Houthuijzen, J. M. [1 ]
Daenen, L. G. M. [1 ]
Roodhart, J. M. L. [1 ]
Voest, E. E. [1 ]
机构：
[1] Univ Med Ctr Utrecht, Dept Med Oncol, NL-3508 GA Utrecht, Netherlands
来源：
BRITISH JOURNAL OF CANCER | 2012年 / 106卷 / 12期
关键词：
mesenchymal stem cells; tumour progression; drug resistance; chemotherapy resistance; ENDOTHELIAL-CELLS; LEUKEMIA CELLS; APOPTOSIS; MICROENVIRONMENT; METABOLISM; SURVIVAL; STROMA; ACID;
D O I：
10.1038/bjc.2012.201
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
It is becoming increasingly clear that the tumour microenvironment has a very important role in tumour progression and drug resistance. Many different cell types within the tumour stroma have an effect on tumour progression either in a positive or in a negative way. Mesenchymal stem cells (MSCs) are a distinct population of cells that have been linked with tumour growth. Mesenchymal stem cells can home to tumours where they modulate the immune system and facilitate tumour growth, angiogenesis and metastasis. Recent studies have shown that MSCs also have an important role in the resistance to various anti-cancer drugs. This mini-review provides an overview of the functional properties of MSCs in tumour progression and drug resistance. British Journal of Cancer (2012) 106, 1901-1906. doi:10.1038/bjc.2012.201 www.bjcancer.com Published online 17 May 2012 (C) 2012 Cancer Research UK
引用
收藏
页码：1901 / 1906
页数：6
相关论文
共 50 条
  • [41] Editorial: Immunity in the development of anti-cancer drug resistance
    Meng, Ya
    Wang, Haitao
    Li, Xuebing
    Wu, Xinwei
    Sun, Heng
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [42] Bone marrow mesenchymal stem cells interact with head and neck squamous cell carcinoma cells to promote cancer progression and drug resistance
    Liu, Chuanxia
    Billet, Sandrine
    Choudhury, Diptiman
    Cheng, Ran
    Haldar, Subhash
    Fernandez, Ana
    Biondi, Shea
    Liu, Zhenqiu
    Zhou, Hongmei
    Bhowmick, Neil A.
    NEOPLASIA, 2021, 23 (01): : 118 - 128
  • [43] Molecular chess? Hallmarks of anti-cancer drug resistance
    Ian A. Cree
    Peter Charlton
    BMC Cancer, 17
  • [44] The dual role of mesenchymal stem cells in tumor progression
    Célia Maria Freitas Gomes
    Stem Cell Research & Therapy, 4
  • [45] Bioengineered Mesenchymal Stem/Stromal Cells in Anti-Cancer Therapy: Current Trends and Future Prospects
    Gil-Chinchilla, Jesus I.
    Zapata, Agustin G.
    Moraleda, Jose M.
    Garcia-Bernal, David
    BIOMOLECULES, 2024, 14 (07)
  • [46] Analysis of biological properties and anti-cancer activity in vitro of mesenchymal stem cells primed with cisplatin
    Tazetdinova, L.
    Solovyeva, V.
    Alekseeva, E.
    Gafiyatullin, A.
    Gomzikova, M.
    Martynova, E.
    Rizvanov, A.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 139 - 140
  • [47] The palladacycle, AJ-5, exhibits anti-tumour and anti-cancer stem cell activity in breast cancer cells
    Aliwaini, Saeb
    Peres, Jade
    Kroeger, Wendy L.
    Blanckenberg, Angelique
    de la Mare, Jo
    Edkins, Adrienne L.
    Mapolie, Selwyn
    Prince, Sharon
    CANCER LETTERS, 2015, 357 (01) : 206 - 218
  • [48] Cancer stem cells as key drivers of tumour progression
    Ayob, Ain Zubaidah
    Ramasamy, Thamil Selvee
    JOURNAL OF BIOMEDICAL SCIENCE, 2018, 25
  • [49] Cancer stem cells as key drivers of tumour progression
    Ain Zubaidah Ayob
    Thamil Selvee Ramasamy
    Journal of Biomedical Science, 25
  • [50] Adhesion-Controlled Proliferation Revealing Anti-Cancer Drug Resistance of Breast Cancer Cells
    Park, Soyeun
    BIOPHYSICAL JOURNAL, 2017, 112 (03) : 122A - 123A
12345